相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The role of cyclic GMP-AMP synthase and Interferon-I-inducible protein 16 as candidatebiomarkers of systemic lupus erythematosus
Qiang Fu et al.
CLINICA CHIMICA ACTA (2022)
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients
Fabio Cacciapaglia et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2022)
The role of PCSK9 in inflammation, immunity, and autoimmune diseases
Johan Frostegard
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2022)
Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
Lisa Zhu et al.
LUPUS SCIENCE & MEDICINE (2022)
All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study
Bahar Moghaddam et al.
RHEUMATOLOGY (2022)
Alterations of Plasma Microbiome: A Potentially New Perspective to the Dysbiosis in Systemic Lupus Erythematosus?
Yudong Liu et al.
JOURNAL OF RHEUMATOLOGY (2022)
Endothelial function and endothelial progenitor cells in systemic lupus erythematosus
Anselm Mak et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus
Christopher B. Oliveira et al.
SEMINARS IN IMMUNOPATHOLOGY (2022)
Therapeutic potential of interleukin-2 in autoimmune diseases
Yeshuang Yuan et al.
TRENDS IN MOLECULAR MEDICINE (2022)
The impact of anti-endothelial cell antibodies (AECAs) on the development of blood vessel damage in patients with systemic lupus erythematosus: the preliminary study
Pawel Cieslik et al.
RHEUMATOLOGY INTERNATIONAL (2022)
High Burden of Premature Arteriosclerosis on Renal Biopsy Results in Incident Lupus Nephritis
Shivani Garg et al.
ARTHRITIS CARE & RESEARCH (2021)
Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus
Fanny Saidoune et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Low-density lipoprotein from active SLE patients is more atherogenic to endothelial cells than low-density lipoprotein from the same patients during remission
Ricardo Rodriguez-Calvo et al.
RHEUMATOLOGY (2021)
Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus
Kerry A. Casey et al.
ARTHRITIS & RHEUMATOLOGY (2021)
The latest in systemic lupus erythematosus-accelerated atherosclerosis: related mechanisms inform assessment and therapy
Brenna D. Appleton et al.
CURRENT OPINION IN RHEUMATOLOGY (2021)
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom
Ana Lorenzo-Vizcaya et al.
LUPUS (2021)
Skin microvascular dysfunction in systemic lupus erythematosus patients with and without cardiovascular risk factors
Nikolaos Koletsos et al.
RHEUMATOLOGY (2021)
Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus
Sara C. Croca et al.
RHEUMATOLOGY (2021)
An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus
Bei-di Chen et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus
Leda Coelewij et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Neutrophil extracellular traps modulate inflammatory markers and uptake of oxidized LDL by human and murine macrophages
Andreas Conforti et al.
PLOS ONE (2021)
Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy
Menglong Xu et al.
EBIOMEDICINE (2021)
Macrophage Polarization and Plasticity in Systemic Lupus Erythematosus
Mariame Mohamed Ahamada et al.
FRONTIERS IN IMMUNOLOGY (2021)
Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells
Bo Zhang et al.
NATURE BIOMEDICAL ENGINEERING (2021)
IL-35 promotes CD4+Foxp3+ Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms
Ying Shao et al.
JCI INSIGHT (2021)
Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus
Lina Wirestam et al.
LUPUS (2021)
PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
Aikaterini Arida et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Hospitalisation for systemic lupus erythematosus associates with an increased risk of mortality in Australian patients from 1980 to 2014: a longitudinal, population-level, data linkage, cohort study
Warren David Raymond et al.
LUPUS SCIENCE & MEDICINE (2021)
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
Ingrid Yao Mattisson et al.
VASCULAR PHARMACOLOGY (2021)
Gut Microbiota in Lupus: a Butterfly Effect?
Rongli Li et al.
CURRENT RHEUMATOLOGY REPORTS (2021)
RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells
Luz P. Blanco et al.
ARTHRITIS & RHEUMATOLOGY (2021)
B Cell-Activating Factor Antagonism Attenuates the Growth of Experimental Abdominal Aortic Aneurysm
Michael D. Spinosa et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation
Alejandra Maria Patino-Trives et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Platelet bound complement split product (PC4d) is a marker of platelet activation and arterial vascular events in Systemic Lupus Erythematosus
Yevgeniya Gartshteyn et al.
CLINICAL IMMUNOLOGY (2021)
STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases
Phuong Tran Pham et al.
EUROPEAN HEART JOURNAL (2021)
Neutralizing interferon-α blocks inflammation-mediated vascular injury via PI3K and AMPK in systemic lupus erythematosus
Xuewei Ding et al.
IMMUNOLOGY (2021)
Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity
Pengchong Li et al.
NATURE IMMUNOLOGY (2021)
Neutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus
Yudong Liu et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2021)
Interferons in Systemic Lupus Erythematosus
Sirisha Sirobhushanam et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2021)
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus
Sarfaraz A. Hasni et al.
NATURE COMMUNICATIONS (2021)
Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus
Brittany N. Weber et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value
Samar M. M. Hammad et al.
FRONTIERS IN IMMUNOLOGY (2021)
The emerging role of neutrophils in autoimmune-associated disorders: effector, predictor, and therapeutic targets
Xiaohong Fu et al.
MEDCOMM (2021)
UPLC-MS/MS-based plasma lipidomics reveal a distinctive signature in systemic lupus erythematosus patients
Jiaxi Chen et al.
MEDCOMM (2021)
Interaction between the STAT4 rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus
Sarah Reid et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
CD34+ CD133+ CD309+ circulating angiogenic cell level is reduced but positively related to hydroxychloroquine use in SLE patients-a case control study and meta-regression analysis
Jinghui Huang et al.
RHEUMATOLOGY (2021)
Immunometabolic Pathways and Its Therapeutic Implication in Autoimmune Diseases
Tingting Wang et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)
Neutrophils in the Pathogenesis of Rheumatic Diseases: Fueling the Fire
Yudong Liu et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)
IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile
Patricia Lopez et al.
RHEUMATOLOGY (2020)
Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease
C. David et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2020)
High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy
Sang Yeop Kim et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
Jing He et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus
Stanley Moore et al.
JOURNAL OF RHEUMATOLOGY (2020)
Angiotensin II receptor agonist antibodies are associated with microvascular damage in lupus nephritis
J. M. Mejia-Vilet et al.
LUPUS (2020)
Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
Hiurma Sanchez-Perez et al.
RHEUMATOLOGY (2020)
Neutrophil Extracellular Traps Participate in Cardiovascular Diseases Recent Experimental and Clinical Insights
Yvonne Doering et al.
CIRCULATION RESEARCH (2020)
Role of Low-Density Lipoprotein in Early Vascular Aging Associated With Systemic Lupus Erythematosus
Hua-Chen Chan et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Lupus nephritis
Hans-Joachim Anders et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
LOX-1: A potential driver of cardiovascular risk in SLE patients
Divya Sagar et al.
PLOS ONE (2020)
Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
Elisabet Svenungsson et al.
RHEUMATOLOGY (2020)
Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients
Goh Murayama et al.
RHEUMATOLOGY (2020)
The Gut Microbiota: Emerging Evidence in Autoimmune Diseases
Xuan Zhang et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients
Medha Barbhaiya et al.
ARTHRITIS CARE & RESEARCH (2020)
Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus
Anquan Liu et al.
LUPUS (2020)
T cells expressing the lupus susceptibility allele Pbx1d enhance autoimmunity and atherosclerosis in dyslipidemic mice
Wei Li et al.
JCI INSIGHT (2020)
Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
Olivia C. Harden et al.
FRONTIERS IN IMMUNOLOGY (2020)
IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus
Xuewei Ding et al.
FRONTIERS IN IMMUNOLOGY (2020)
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus
Alessandra Bortoluzzi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Atherosclerosis in SLE: a potential role for serum parathormone levels
Mayra Giannelou et al.
LUPUS SCIENCE & MEDICINE (2020)
Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus
Patricia Lopez et al.
RHEUMATOLOGY (2020)
Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice
Tatjana Josefs et al.
JCI INSIGHT (2020)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The cytokine network type I IFN-IL-27-IL-10 is augmented in murine and human lupus
Michael H. Lee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations
Marina Rodriguez et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
Human low-affinity IgG receptor FcRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus
Robert Clancy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE
Michelle A. Petri et al.
LUPUS SCIENCE & MEDICINE (2019)
Development of a systemic lupus erythematosus cardiovascular risk equation
Michelle A. Petri et al.
LUPUS SCIENCE & MEDICINE (2019)
Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE
Maureen Mcmahon et al.
LUPUS SCIENCE & MEDICINE (2019)
Prevalence of coronary artery calcification in young patients with SLE of predominantly Hispanic and African-American descent
Yevgeniya Gartshteyn et al.
LUPUS SCIENCE & MEDICINE (2019)
B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus
Francesca Romana Spinelli et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus
S. Mavrogeni et al.
LUPUS (2018)
Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis
Dag Leonard et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis
Maria Wigren et al.
ATHEROSCLEROSIS (2018)
IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors
Jitong Sun et al.
ATHEROSCLEROSIS (2018)
Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis
Maira Giannelou et al.
CLINICAL IMMUNOLOGY (2018)
Cardiovascular disease in systemic lupus erythematosus: an update
Yudong Liu et al.
CURRENT OPINION IN RHEUMATOLOGY (2018)
Cardiorespiratory fitness and age-related arterial stiffness in women with systemic lupus erythematosus
Cristina Montalban-Mendez et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
B-cell activating factor and related genetic variants in lupus related atherosclerosis
Evangelos Theodorou et al.
JOURNAL OF AUTOIMMUNITY (2018)
PCSK9 plays a novel immunological role in oxidized LDL-induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque
A. Liu et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Increased visceral adipose tissue and altered adiposity distribution in premenopausal lupus patients: correlation with cardiovascular risk factors
L. P. C. Seguro et al.
LUPUS (2018)
Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27
Heeju Ryu et al.
NATURE IMMUNOLOGY (2018)
The non-haemostatic role of platelets in systemic lupus erythematosus
Petrus Linge et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Disease trends over time and CD4+CCR5+ T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus
A. Baragetti et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2018)
Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis
Yudong Liu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Elevation of serum proprotein convertase subtilisin/kexin type 9 (PCSK9) concentrations and its possible atherogenic role in patients with systemic lupus erythematosus
Chenglong Fang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus
Nicola Edwards et al.
LUPUS SCIENCE & MEDICINE (2018)
Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus
Philip M. Carlucci et al.
JCI INSIGHT (2018)
Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity
Carolyne K. Smith et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
Yasuko Furumoto et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Dyslipidemia in systemic lupus erythematosus
Melinda Zsuzsanna Szabo et al.
IMMUNOLOGIC RESEARCH (2017)
IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus
Joy Jones Buie et al.
JOURNAL OF IMMUNOLOGY (2017)
Oxidized Low-Density Lipoprotein Immune Complex Priming of the Nlrp3 Inflammasome Involves TLR and FcγR Cooperation and Is Dependent on CARD9
Jillian P. Rhoads et al.
JOURNAL OF IMMUNOLOGY (2017)
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano et al.
JOURNAL OF RHEUMATOLOGY (2017)
LOX-1 in Atherosclerosis and Myocardial Ischemia Biology, Genetics, and Modulation
Naga Venkata K. Pothineni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
IRF3 and type I interferons fuel a fatal response to myocardial infarction
Kevin R. King et al.
NATURE MEDICINE (2017)
Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort study
Chung-Yuan Hsu et al.
RHEUMATOLOGY (2017)
Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus
Patricia Lopez et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study
J. Antonio Avina-Zubieta et al.
ARTHRITIS CARE & RESEARCH (2017)
The gut microbiome in atherosclerotic cardiovascular disease
Zhuye Jie et al.
NATURE COMMUNICATIONS (2017)
Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
Medha Barbhaiya et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls
Johanna T. Gustafsson et al.
PLOS ONE (2017)
Cardiovascular risk profiles in a lupus cohort: what do different calculators tell us?
Daniel Boulos et al.
LUPUS SCIENCE & MEDICINE (2017)
Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE
Lina Wirestam et al.
LUPUS SCIENCE & MEDICINE (2017)
Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study
Hilda J. I. De Jong et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Stroke in systemic lupus erythematosus: a Swedish population-based cohort study
Elizabeth V. Arkema et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a crosssectional controlled study
Gillian Divard et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Association of aortic perivascular adipose tissue density with aortic calcification in women with systemic lupus erythematosus
Kelly J. Shields et al.
ATHEROSCLEROSIS (2017)
Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition
Elmar Pieterse et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1 Pathway in Systemic Lupus Erythematosus
Sokha Nhek et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Effects of Long-Term Type I Interferon on the Arterial Wall and Smooth Muscle Progenitor Cells Differentiation
Yanpeng Diao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Senescent profile of angiogenic T cells from systemic lupus erythematosus patients
Patricia Lopez et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus
R. Castejon et al.
LUPUS (2016)
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Munther Khamashta et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis
Jie Li et al.
CIRCULATION RESEARCH (2016)
IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms
Mizanur Rahman et al.
CLINICAL IMMUNOLOGY (2016)
Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus
Murray B. Urowitz et al.
JOURNAL OF RHEUMATOLOGY (2016)
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Jing He et al.
NATURE MEDICINE (2016)
Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease
Christian Lood et al.
NATURE MEDICINE (2016)
Brief Report: Trends in Hospitalizations Due to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus Erythematosus, 1996 to 2012
Maria G. Tektonidou et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Vitamin D Deficiency Is Associated With Endothelial Dysfunction and Increases Type I Interferon Gene Expression in a Murine Model of Systemic Lupus Erythematosus
John A. Reynolds et al.
Arthritis & Rheumatology (2016)
Dynamics of pulse wave velocity and vascular augmentation index in association with endothelial progenitor cells in SLE
Peter Korsten et al.
LUPUS SCIENCE & MEDICINE (2016)
Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaque
Edward Smith et al.
SCIENCE IMMUNOLOGY (2016)
Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study
Hsin-Hui Yu et al.
ATHEROSCLEROSIS (2015)
How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae
Handrean Soran et al.
CURRENT OPINION IN LIPIDOLOGY (2015)
CD4+CXCR3+T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus
Marc Clement et al.
JOURNAL OF AUTOIMMUNITY (2015)
Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Annika Warnatsch et al.
SCIENCE (2015)
Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice
Jason S. Knight et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice
Ashley J. Wilhelm et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2
Carmelo Carmona-Rivera et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors
Alyssa M. Cates et al.
RHEUMATOLOGY (2015)
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus
Nicoletta Ronda et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Subclinical Atherosclerosis in Systemic Lupus Erythematosus and Antiphospholipid Syndrome Focus on β2GPI-Specific T Cell Response
Fabrizio Conti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis
Jason S. Knight et al.
CIRCULATION RESEARCH (2014)
The association of serum parathyroid hormone and severity of coronary artery diseases
Shadi Shekarkhar et al.
CORONARY ARTERY DISEASE (2014)
Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosus
Tamar R. Aprahamian et al.
IMMUNOLOGY (2014)
Involvement of TLR4 in Oxidized LDL/β2GPI/Anti-β2GPI-Induced Transformation of Macrophages to Foam Cells
Xiaolei Zhang et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)
oxLDL/β2GPI/anti-β2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway
Ya Xu et al.
THROMBOSIS RESEARCH (2014)
A Panel of Biomarkers Is Associated With Increased Risk of the Presence and Progression of Atherosclerosis in Women With Systemic Lupus Erythematosus
Maureen McMahon et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Neutrophil Extracellular Trap-Derived Enzymes Oxidize High-Density Lipoprotein An Additional Proatherogenic Mechanism in Systemic Lupus Erythematosus
Carolyne K. Smith et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Coronary Heart Disease in Systemic Lupus Erythematosus Is Associated With Interferon Regulatory Factor-8 Gene Variants
Dag Leonard et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2013)
Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with Systemic Lupus Erythematosus (SLE)
Zhu Mengya et al.
CLINICAL RHEUMATOLOGY (2013)
Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus
Jason S. Knight et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
BAFF Receptor mAb Treatment Ameliorates Development and Progression of Atherosclerosis in Hyperlipidemic ApoE-/- Mice
Tin Kyaw et al.
PLOS ONE (2013)
Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr-/- mice
Sander I. van Leuven et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Use of statins is associated with an increased risk of rheumatoid arthritis
H. J. I. de Jong et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells
Thore Dietrich et al.
ATHEROSCLEROSIS (2012)
Auto-Antigenic Protein-DNA Complexes Stimulate Plasmacytoid Dendritic Cells to Promote Atherosclerosis
Yvonne Doering et al.
CIRCULATION (2012)
IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE
Caroline Groenwall et al.
CLINICAL IMMUNOLOGY (2012)
Association between Serum Total Antioxidant Status and Coronary Microvascular Functions in Patients with SLE
Sema Yilmaz et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2012)
Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial
J. G. Juarez-Rojas et al.
LUPUS (2012)
Accelerated atherosclerosis in patients with SLE-mechanisms and management
Brian J. Skaggs et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients
Emily C. Somers et al.
PLOS ONE (2012)
Lupus Atherosclerosis Prevention Study (LAPS)
M. A. Petri et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Interferon-α Priming Promotes Lipid Uptake and Macrophage-Derived Foam Cell Formation A Novel Link Between Interferon-α and Atherosclerosis in Lupus
Jia Li et al.
ARTHRITIS AND RHEUMATISM (2011)
Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study
Justin T. Saunders et al.
CIRCULATION (2011)
Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus
Eneida Villanueva et al.
JOURNAL OF IMMUNOLOGY (2011)
Endothelium-dependent But Not Endothelium-independent Flow-mediated Dilation Is Significantly Reduced in Patients with Systemic Lupus Erythematosus without Vascular Events: A Metaanalysis and Metaregression
Anselm Mak et al.
JOURNAL OF RHEUMATOLOGY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity
Young-Nan Cho et al.
RHEUMATOLOGY (2011)
Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus
Roberto Lande et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Association Between Statin Use and Lupus-Like Syndrome Using Spontaneous Reports
Hilda J. I. de Jong et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Macrophage Activation and Coronary Atherosclerosis in Systemic Lupus Erythematosus and Rheumatoid Arthritis
Young Hee Rho et al.
ARTHRITIS CARE & RESEARCH (2011)
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease
Christian Lood et al.
BLOOD (2010)
Myeloid Type I Interferon Signaling Promotes Atherosclerosis by Stimulating Macrophage Recruitment to Lesions
Pieter Goossens et al.
CELL METABOLISM (2010)
Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death
Anurag Kumar Gupta et al.
FEBS LETTERS (2010)
Nuclear Magnetic Resonance Lipoprotein Subclasses and the APOE Genotype Influence Carotid Atherosclerosis in Patients with Systemic Lupus Erythematosus
Marta Gonzalez et al.
JOURNAL OF RHEUMATOLOGY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Long-term improvement of lipid profile in patients with refractory systemic lupus erythematosus treated with B-cell depletion therapy: a retrospective observational study
Jose M. Pego-Reigosa et al.
RHEUMATOLOGY (2010)
Platelet CD154 Potentiates Interferon-α Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus
Pierre Duffau et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
oxLDL/β2GPI complex and anti-oxLDL/β2GPI in SLE: Prevalence and correlates
N. Bassi et al.
AUTOIMMUNITY (2009)
Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women A Meta-analysis
Satoru Kodama et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Improves Cardiometabolic Risk and Renal Inflammation in Murine Lupus
Wenpu Zhao et al.
JOURNAL OF IMMUNOLOGY (2009)
Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus
Trina Thompson et al.
ARTHRITIS AND RHEUMATISM (2008)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus
Pui Y. Lee et al.
ARTHRITIS AND RHEUMATISM (2007)
Inteirferon-α promotes abnormal vasculogenesis in lupus:: a potential pathway for premature atherosclerosis
Michael F. Denny et al.
BLOOD (2007)
Identification of a novel role of T cells in postnatal vasculogenesis - Characterization of endothelial progenitor cell colonies
Jin Hur et al.
CIRCULATION (2007)
Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial
G. A. Ferreira et al.
RHEUMATOLOGY (2007)
Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis
Maureen McMahon et al.
ARTHRITIS AND RHEUMATISM (2006)
Vascular diseases and their risk factors in IgA nephropathy
Juhani Myllymaki et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis
J Golledge et al.
STROKE (2004)
Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus
JB Soep et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity
S Rajagopalan et al.
BLOOD (2004)
Circulating oxidized LDL forms complexes with β2-glycoprotein I:: implication as an atherogenic autoantigen
K Kobayashi et al.
JOURNAL OF LIPID RESEARCH (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antibodies to high-density lipoprotein and β2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome
JD Alves et al.
ARTHRITIS AND RHEUMATISM (2002)